Clinical development of inhibitors of the PI3K

被引：0
|
作者：
Saura Manich, C. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-TS2-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TS2-2
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Challenges in the clinical development of PI3K inhibitors
    Massacesi, Cristian
    di Tomaso, Emmanuelle
    Fretault, Nathalie
    Hirawat, Samit
    [J]. INOSITOL PHOSPHOLIPID SIGNALING IN PHYSIOLOGY AND DISEASE, 2013, 1280 : 19 - 23
  • [2] Current clinical development of PI3K pathway inhibitors in glioblastoma
    Wen, Patrick Y.
    Lee, Eudocia Q.
    Reardon, David A.
    Ligon, Keith L.
    Yung, W. K. Alfred
    [J]. NEURO-ONCOLOGY, 2012, 14 (07) : 819 - 829
  • [3] The development of inhibitors of PI3K and Akt
    Dennis, PA
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [4] Development and safety of PI3K inhibitors in cancer
    Miaomiao Yu
    Jiajia Chen
    Zhifei Xu
    Bo Yang
    Qiaojun He
    Peihua Luo
    Hao Yan
    Xiaochun Yang
    [J]. Archives of Toxicology, 2023, 97 : 635 - 650
  • [5] Development of PI3Kα inhibitors for tumor therapy
    Jia, Wenqing
    Luo, Shuyu
    Guo, Han
    Kong, Dexin
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (17): : 8587 - 8604
  • [6] Development and safety of PI3K inhibitors in cancer
    Yu, Miaomiao
    Chen, Jiajia
    Xu, Zhifei
    Yang, Bo
    He, Qiaojun
    Luo, Peihua
    Yan, Hao
    Yang, Xiaochun
    [J]. ARCHIVES OF TOXICOLOGY, 2023, 97 (03) : 635 - 650
  • [7] Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review)
    Meng, Dandan
    He, Wei
    Zhang, Yan
    Liang, Zhenguo
    Zheng, Jinling
    Zhang, Xu
    Zheng, Xing
    Zhan, Peng
    Chen, Hongfei
    Li, Wenjun
    Cai, Lintao
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 173
  • [8] Development of PI3K inhibitors: lessons learned from early clinical trials
    Jordi Rodon
    Rodrigo Dienstmann
    Violeta Serra
    Josep Tabernero
    [J]. Nature Reviews Clinical Oncology, 2013, 10 : 143 - 153
  • [9] Clinical development of PI3K/AKT pathway inhibitors in breast cancer.
    Derynck, Mika
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 22 - 22
  • [10] Development of PI3K inhibitors: lessons learned from early clinical trials
    Rodon, Jordi
    Dienstmann, Rodrigo
    Serra, Violeta
    Tabemero, Josep
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (03) : 143 - 153
12345